akst4290
Showing 1 - 3 of 3
Neovascular Age-related Macular Degeneration Trial in Worldwide (AKST4290, Placebo, Aflibercept)
Completed
- Neovascular Age-related Macular Degeneration
- AKST4290
- +2 more
-
Beverly Hills, California
- +20 more
Oct 24, 2022
Diabetic Retinopathy Trial in United States (AKST4290, Placebo)
Suspended
- Diabetic Retinopathy
- AKST4290
- Placebo
-
Phoenix, Arizona
- +16 more
Mar 4, 2022
Pemphigoid, Bullous Trial in Germany (Mometasone furoate, AKST4290, Placebo)
Completed
- Pemphigoid, Bullous
- Mometasone furoate
- +2 more
-
Dresden, Germany
- +7 more
Jul 6, 2021